Loading interface...

Fibral 200 Tablet

Manufactured byMicro Labs Ltd.
ContainsFenofibrate
Description

Fibral 200 Tablet is used to decrease high cholesterol and triglycerides levels in the blood. It increases high-density lipoproteins (HDL) which reduce the risk of heart attacks. This medicine used along with a proper diet to control high cholesterol and triglyceride levels. This medicine should be used with caution in elderly patients. It is not recommended for use in children. Close monitoring of kidney and liver functions is recommended during treatment with this medicine.

Substitutes

List of substitutes for Fibral 200 Tablet

Lotgl 200 mg Tablet
Strides Shasun Ltd.

Side effects

Major & minor side effects for Fibral 200 Tablet

  • Chills and fever
  • Itching and skin rash
  • Nausea and Vomiting
  • Headache
  • Shortness of breath
  • Weakness
  • Runny Nose
  • Stuffy Nose
  • Increased sensitivity of the skin to sunlight

Uses of Fibral 200 Tablet

What is it prescribed for?

  • Severe hypertriglyceridemia
  • Hypercholesterolemia
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The time required for this medicine to show its action is not clinically established.
  • How long do the effects of this medicine last?
    The time until which this medicine remains active in the body is not clinically established.
  • Is it safe to consume alcohol while taking this medicine?
    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
  • Is this a habit forming medicine?
    No habit forming tendency has been reported.
  • Can this medicine be taken during pregnancy?
    This medicine is not recommended for use in pregnant women unless necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.
  • Can this medicine be taken while breast-feeding?
    This medicine is not recommended for use in breastfeeding women. Your doctor may prescribe an alternative medicine based on your clinical condition.

Allergy

This medicine is not recommended for use if you have a known allergy to fenofibrate or any other inactive ingredients present in the formulation.

Gallbladder disease

This medicine is not recommended for use in patients with a known history of gallbladder diseases due to the increased risk of gallbladder stones.

Active liver disease

This medicine is not recommended for use in patients with active liver diseases due to the increased risk of worsening the patient's condition.

Severe kidney impairment

This medicine is not recommended for use in patients with severe kidney disease, (including dialysis) due to the increased risk of worsening the patient's condition.
Warnings for special population

Pregnancy

This medicine is not recommended for use in pregnant women unless necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.

Breast-feeding

This medicine is not recommended for use in breastfeeding women. Your doctor may prescribe an alternative medicine based on your clinical condition.
General warnings

Cholelithiasis

This medicine should be used with caution due to the increased risk of gallbladder stones. This risk is especially higher in patients with a history of liver or gallbladder diseases. Appropriate dose adjustments or replacement with a suitable alternative may be necessary based on the clinical condition of the patient.

Hematologic Changes

This medicine should be used with caution due to the risk of a decrease in the hemoglobin, hematocrit, and white blood cell count. Close monitoring of complete blood count is recommended in patients receiving this medicine.

Increase in serum creatinine levels

Close monitoring of renal function is recommended in patients receiving this medicine due to the increased risk of elevated serum creatinine levels.

Concomitant oral Anticoagulants

This medicine should be used with caution along with anticoagulants due to the risk of excessive bleeding. Appropriate dose adjustments or replacement with a suitable alternative may be necessary based on the clinical condition of the patient.

Rhabdomyolysis

This medicine may cause a fatal condition called rhabdomyolysis where the muscles in the body are damaged and which may ultimately result in kidney damage. Close monitoring of kidney function is necessary during treatment with this medicine.

Missed Dose

Take the missed dose as soon as you remember. If it is almost time for your next scheduled dose, skip the missed dose. Do not double your dose to make up for the missed one.

Overdose

Seek emergency medical treatment or contact the doctor in case of an overdose.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Instructions

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Interaction with Medicine

Repaglinide

Glimepiride

Simvastatin

Lovastatin

Cyclosporine

Disease interactions

Rhabdomyolysis

This medicine is not recommended for use in patients with a known history of Rhabdomyolysis due to the increased risk of renal failure and death. Any symptoms such as muscle pain, weakness, or joint pain and swelling should be reported to the doctor on priority. Replacement with a suitable alternative should be considered under your doctor's supervision.
Food interactions
Information not available.
Lab interactions
Information not available.
Take this medicine exactly as instructed by the doctor. Do not take larger amounts than prescribed. Seek emergency medical treatment in case of any side effects. Ensure that the course of treatment is completed. Do not stop the use of this medicine without consulting your doctor.
Miscelleneous

Can be taken with or without food, as advised by your doctor

To be taken as instructed by doctor

Does not cause sleepiness

How it works
It works by increasing the natural lipid breakdown process with the help of enzyme lipoprotein lipase. This removes the bad cholesterol and triglycerides from the blood and increases the levels of good cholesterol (HDL).
Legal Status

Approved

Approved

Approved

Approved

Classification

Category

Fibric acid derivatives

Schedule

Schedule H

Fenofibrate: MedlinePlus Drug Information [Internet]. Medlineplus.gov. 2020 [cited 29 May 2020]. Available from:

https://medlineplus.gov/druginfo/meds/a601052.html

[Internet]. Medicines.org.uk. 2020 [cited 29 May 2020]. Available from:

https://www.medicines.org.uk/emc/files/pil.5267.pdf

TRICOR® 48 mg and 145 mg (fenofibrate tablets) [Internet]. Dailymed.nlm.nih.gov. 2020 [cited 29 May 2020]. Available from:

https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=194cd14a-d952-4507-91be-3f1d5371d3b8&type=display

[Internet]. Accessdata.fda.gov. 2020 [cited 29 May 2020]. Available from:

https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021656s029lbl.pdf

Fenofibrate - DrugBank [Internet]. Drugbank.ca. 2020 [cited 29 May 2020]. Available from:

https://www.drugbank.ca/drugs/DB01039
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 2 Jun 2020

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.